Improving diabetes care with wearable sensors
Part of Hormones & metabolism clinical trials.
This study tests if wearing two devices (a continuous glucose monitor and a sports wristband) can help improve diabetes care. It focuses on people with type 2 diabetes who live in certain Chicago neighborhoods and are willing to use the devices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with type 2 diabetes
- You live in one of these Chicago zip codes: 60619, 60620, 60621, 60636, 60644, 60624, 60609, 60612, 60617, 60623, 60628, 60629, 60639, 60645, 60649, 60651, 60652, 60653
- You speak and understand English
- You are willing to wear a continuous glucose monitor and a sports wristband
- You own a smartphone
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study tests a new app combined with a smartwatch and glucose monitor to predict your blood sugar patterns and help you manage Type 2 Diabetes better. You'll use your phone, watch, and existing glucose monitor to share data that an AI system learns from.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This study tests whether a team of community health worker and pharmacist can help improve blood sugar control in people with type 2 diabetes. You may be asked to use a continuous glucose monitor (a sensor that tracks sugar levels) and take part in support visits.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
This trial tests using a smartphone to help manage your blood sugar. It's for people with type 2 diabetes who take insulin and whose blood sugar is not well controlled (HbA1c 8% or higher).
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.